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Nonlinearity Of Dose-Response
Functions For Carcinogenicity
by David G. HoeI1'2 and ChristopherJ. Portier2
Carcinogenesis datafor315chemicalswereobtainedfromtheNationalCancerInstitute-National ToxicologyProgram
(NCI-NTP)bioassay programsandwereanalyzedtoexaminetheshapeofcarcinogenesisdose-responsecurves. Tumor
site data were moreoftenconsistent withaquadratic response thanwithalinear response,suggesting thatthe routine
useoflineardose-responsemodels willoftenoverestimate risk. Informationfromin vivoshort-termmutagenicity and
genotoxicity assayswasalsoobtainedformostoftheserodentbiossanys. Itwasfoundthattherewerenoclearrelationships
betweentheshapeofthecarcinogenesisdose-responsecurveandtheresultoftheshort-termtest. Theseobservationsargue
againsttheconceptthatcarcinogensthatarepositiveinashort-termassayberegulatedusingalineardose-responsecurve
andthose that are negative beregulated usingasublineardose-responsecurveorasafety factorapproach.
Introduction
One of the more controversial issues in chemical carcino-
genesis is thatofestimating low-doseeffects (1-7). Because of
sample sizeconsiderations, experimentaldatamustbeobtained
at relatively high exposure levels and then necessarily ex-
trapolated to relatively low human exposure levels (5-7).
Although thebasic mechanismsofcarcinogenicity are notwell
understood, itisbelieved thatthe process ismultistage (2,8-13).
Ifthis isthe case, adose-response curvefor acarcinogenwould
expectablydepend onthetransitionbetweenparticular stages or
the clonal expansion of cells in a particular stage that the
chemical affects (1,2,4,11-16). For example, the first stage is
thought toinvolvemutationalchangesintheDNA as aresultof
what is believed to be a linear-in-dose genotoxic effect ofthe
chemical (1,2,4,11,12,15). Chemical promoters canenhancethe
expansion ofthese mutated cells by a selective growth process
thatisgenerally assumedtobenonlinear(1,2,4,11,12,15). Later
steps, such as progression, can also be chemically dependent
with both linear and nonlinear dose-response relationships
(12,15,17). Note also that the chemical itself can undergo
metabolic changesthat may lead to anonlinearrelationshipbe-
tweentheadministered chemical andtheeffectivemetabolitethat
induces carcinogenesis (3,18).
Accurate determination of the shape of the dose-response
curve is critical to predicting low-dose risks. Some dose-
response models have the property that they are "low-dose
linear," or "linear" for short(4). A lineardose-responsemodel
is amodel inwhichtheslopeofthedose-response curveevalu-
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atedatdosezeroispositiveandproportionaltodose. Onesuch
modelistheone-hit/one-stagemodel. Othermodelsexhibitcur-
vatureforwhichtheslopeofthedose-responsecurveisequalto
zeroatdosezero. Thetwo-hit/one-stageorquadraticmodelisan
exampleofsuchamodel. Finally, somemodelsexhibitcurvature
that is greater than linear in the low-dose range. A model that
typifies this type of response is the square-root model. The
mathematical descriptions of these models are given in the
Methods section. These three simple models (square-root,
linear, and quadratic) include the three types of qualitative
behaviormostfrequentlyconsideredincarcinogenesis studies
(e.g., supralineardoseresponse, lineardoseresponse, andsub-
lineardose response).
Inexaminingexperimentalcarcinogenesis datafromapublic
healthstandpoint, wefindthatadose-responsefunctionthatis
linearinlowdoseswill typically fittheobserveddataand will
usuallyoverestimatetheobservedcarcinogenic riskatthelow-
doselevel. Thus, thelinearmodelisconsideredtobeaconser-
vative model. However, it is importanttodetermine the actual
degreetowhichthelinearmodelisconservative. Oneapproach
to evaluating linearity versus nonlinearity is to examine the
availableanimaldata. Inthispaperwefocusontwoquestions:
a)Whatistheusualshapeofthedose-responsecurveforcarcin-
ogenicresponsetoenvironmentalagents?andb) Doshort-term
in vitro genotoxicity assays predict the shape ofthese dose-
responsecurves? Toanswerthesequestions, wehaveanalyzed
datafromtheNCI/NTP2-yearrodentcarcinogenesisstudiesand
from in vitroassays formutagenicityandgenotoxicity.
Data and Statistical Methods
Inanyanalysisofcarcinogenesisdata,oneisfacedwiththedif-
ficultiesofdealingwith smallsamplesizes. Thecarcinogenesis
datageneratedfromthesesmallsamplesareoftenconsistentwith
many different dose-response functions, including a linearHOELANDPORTIER
¶hble 1. Combinations ofprimary tumor sites.
All squamous cell and basal cell papillomas, adenomas, andcarcinomasofthe
skin
All fibroma and fibrosarcoma ofthe subcutaneous tissue
Alveolar bronchiolar adenomas and carcinomas ofthe lung
All nasal cavity tumors
All hematopoietic system tumors
All circulatory system tumors
Adenomas/nodules and carcinomas ofthe liver
Adenomas and adenocarcinomas ofthe tubularcells ofthe kidney
Papillomas and carcinomas ofthetransitional cells ofthe kidney
All urinary bladder tumors
All pituitary tumors
All pheochromocytomas ofthe adrenal gland
Adenomas and carcinomas ofthe adrenal cortex
Adenomas and carcinomas ofthe thyroid C-cells
Adenomas and carcinomas ofthe thyroid follicularcells
All tumors ofthe parathyroid
Adenomas and carcinomas ofthe pancreas islet cells
Squamous cell papilloma and carcinoma ofthe forestomach
All tumors ofthe mammary gland
Interstitial cell tumors ofthe testis
Endometrial stromal polyps and sarcomas ofthe uterus
All tumors ofthe zymbal gland
All mesothelioma
dose-response function. However, onecouldjustaseasily test
to seewhetherthedataareconsistentwithaparticularnonlinear
hypothesis, suchasaquadraticdose-response function. Because
ofthesmall samplesizes, onefindsthatthedatawillalsobecon-
sistentwith several nonlineardose-responsefunctions (19). We
areinterested inthedegreetowhichcarcinogenicity dataareac-
tuallyconsistentwithlinearityandwhetherotherpossibledose-
response functions may be more appropriate.
Ouranalysis isbasedontumorigenicity datafrom344rodent
bioassays on 315 chemicals studied by the NCI and the NTP
(20,21). Foreachbioassay, cancersiteswereidentified. Theterm
"site" refers to a specific tumor or class oftumors in one sex/
speciesgroupforonechemical. Thus,becausetheNTPfeeding
study of 2,3,7,8-tetrachlorodibenzo-p-dioxin (22) recorded
significant increases in both thyroid follicular-cell tumors and
liver tumors, there would be at least two sites listed for the
animals in this study. The tumor Standard Nomenclature of
Pathology (SNOP)codesrecordedbytheNC/NTPpathologists
were not analyzed individually, but instead were grouped as
giveninTable 1. IftumorSNOPcodeswererecordedthatdidnot
agreewithanyoftheclassifications showninTable 1,they were
groupedbytissuesiteandanalyzedseparately. Finally, wealso
considered agroupingofalltumor-bearinganimals(excluding
interstitialcelltumorsofthetestesinmaleFischer344rats). In
the344rodentbioassays weinvestigated, therewere21,463 sites.
Many ofthese sites are not related to exposure to thechemical
andwereexcluded fromtheanalysis. Weconsideredtwosubsets
of the full set of21,463 sites; we analyzed all sites that were
statistically significant at a = 0.01 using the adjusted quantal
response test(23,24) andall sites with a = 0.05.
Whentestingata = 0.01, ouroverallagreementwiththecalls
madebytheNCI/NTPreviewboardswasgood. Forexample,of
the298experimentsthatincludedmalemice, wefound68ofthe
83 NCI/NTPpositivesand 153ofthe 174negatives(mostofthe
inadequate studies and equivocal results were found to be
negative: 29/41). The difference between our results and the
NCI/NTPcalls isduetoa) ourinability torecognize asignifi-
cant raretumor, b) ouruseofa survival-adjusted test for early
NCIexperiments, andc)theuseofall tumor-bearing animals,
a grouping not used by the NCI/NTP. The general results we
observed fora = 0.05 were similar to those observed for a =
0.01, and thus weonly present the results forca = 0.01.
For each sex-by-species-by-chemical-by-route combination,
there may be several sites exhibiting a significantly increased
cancerrisk. Historically, riskassessmentshavebeendoneusing
eitherthemostpotenttumorsiteoracombinationoftumorsites.
To mimic what is done in practice, our first analysis presents
results forthesitewiththesteepestdose-responsecurve (most
potentsite)amongallsignificantsites(a = 0.01)foreachsex-by-
species-by-chemical-by-route combination.
A model ofthe form
P ( d )=1 - e-Yly2dS (1)
was fit to all cancer sites using the survival-adjusted quantal
response (23,24), where (3 was fixed at one of three values,
(3=0.5 (a square-root model), (3=1 (a linear model), (3=2 (a
quadratic model). Foreachcancersitewedetermined whether
theestimateddose-response relationship wasconsistent witha
linear, quadratic, or square-rootmodel using a standard testof
goodness of fit (25), testing at a=0.10. We were also able to
determine iftheobserveddatahad more or less curvature than
the fitted model (e.g., in the case ofa linear model, more cur-
vature would correspond to a quadratic or higher [(3>2] re-
sponse, lesscurvature toasquarerootorless response[( < ½/2])
by evaluating the partial derivative of the log-likelihood with
respect to the shape ((3) ofthe dose-response curve.
Results
In Vivo Dose-Response Shape
Table 2 summarizes the resultsofouranalysisofthe routine
shapesofdose-responsecurves. InTable2 (partA) we seethat
67% (260/390)oftheexperimentalresultsareconsistentwithall
threeofthemodelsand 84% (326/390) areconsistentwith two
ormoremodels. Itisclearthatthelinearmodel fitsmostofthe
data(327/390)andthatallthreemodelsfitmuchofit. Ifwelook
atthemodelthatbestfitstheexperimental datawithoutregard
totheadequacy ofthisfit(Table2, partB), wefindthat33% of
thesitesfitthesquare-rootmodelbest,20% fitthelinearmodel
best, and 47% fit the quadratic model best. Thus, a quadratic
dose-response function provides a best fit to the observed ex-
perimental results morefrequentlythandoesalinearcurveora
square-rootcurve.
Anotherwaytocharacterizedose-responseshapeistoassign
ashape toeachchemicalusing allpositive sites insteadofonly
themostpotentsite. Thiscanonlybedonereliablyforchemicals
forwhich allsignificantsites havethe same shape. The results
show that 58% ofthe chemicals with at least one significant
tumorsitehaveamixtureofdose-responseshapes(Table2, part
C). Morenotably, ofthe75 chemicals forwhichall significant
siteshadonlyoneshape, most(81%)havesolelyquadraticdose-
responsedata. Thenumberofsitesforeachofthese75chemicals
differedaccording totheshapeofthedose-responsecurve. Eight
ofthe9linearchemicalsarJ2ofthe5square-rootchemicalshad
only 1 significantsite. The 1 remaininglinearchemicalandthe3
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Table 2. Consistency ofcarcinogenesis datawith square root, lnear, and
quadratic dose-responsemodels.
a PartA:Testing forconsistency with various models
L,Sr, L,SR, LQ SR L Q None None
Q NotQ not SR only only only but <SR but >Q
260 36 30 7 1 35 1 20
Part B: Best fitsa
SR L Q Total
129 (33 ) 77 (20) 184 (47) 390
Part C: Classifying chemicalsC
Cased SR L Q Mixed Total
A 5 (2.8) 9 (5.1) 61 (34.5) 102 (57.6) 177
B 50 (12.8) 45 (11.5) 160(41.0) 135 (34.6) 390
Abbreviations: SR, square root; L, linear; Q quadratic.
aFor each sex/species/route/chemical combination examined, the cases
reported are forthe tissue site with the maximum slope forthedose-response
curve underthe linearmodel.
bNumbers inparentheses are percents.
CEntries arethe numberofdata sets forwhichall significant tumorsites were
best fit by square root, linear, etc.
dThe cases are (A) each chemical (multiple routes and technical reports are
treated asdifferent chemicals) formsonedata settestedatthe0.01 level; (B)each
sex-by-species-by-chemical combination forms one data set, tested atthe0.01
level.
remaining square-rootchemicalshadonly2significantsites. On
theotherhand, forthequadraticchemicals, 3had6or moresites,
1 had 5 sites, 6 had 4 sites, 4 had 3 sites, 13 had 2 sites, and 34
had only 1 significant site. Thus, the evidence for nonlinear
dose-response is stronger for quadratic-only chemicals thanit
is forsquare-root-only orlinear-only chemicals. If, insteadofall
sitesforeachchemical, weconsiderallsignificantsitesforeach
sex-by-species-by-chemical combination (case B), there are
fewer cases where the results are a mixture of models (only
35%). Again, quadratic models dominate with 63% (160/255)
ofthe unequivocal calls.
To illustrate these findings forspecific chemicals, considerthe
listof 10examples provided by Baileretal. (26,27), ofsites that
exhibited square-rootdose responsefromanimalcarcinogenesis
experiments, eight of which were also in our database (1,4-
methylenedianiline2HCl, 1,2-dibromoethane, 1,4-dioxane, 1,3-
butadiene, dimethylvinyl chloride, cytembena, l,5-naphthalene
diamine andiodinated glycerol). In all eight cases, we find that
the square-root model best fits these data for the specific site
chosenbyBailer. However wealso findthatall eightchemicals
producedtumors at numerous sites, andin no case wereallofthe
significant sites square-root in shape. In addition, we find that
for the tumor sites chosen by Bailer, the data also fit the quadratic
modelforfourofthechemicals(1,2-dibromoethane, 1,4-dioxane,
dimethylvinyl chloride, and 1,5-napthaline diamine) and the
linear model for seven of the chemicals (all except iodinated
glycerol). For one chemical (iodinated glycerol), none of the
three models adequately fit the data (although these data are
clearly moreextremethansquare-root). Infiveoftheeightcases,
the survival-adjusted quantal response for the two dose groups
exceeded75%, providing littleinformation on curvaue. Fortwo
of these chemicals (1,2-dibromoethane and dimethylvinyl
chloride), the response, infact, exceeded 95% for both doses,
whichprovides noinformation oncurvature. Thus, looldngatthe
best-fitting curvefor onesite for achemical does notnecessarily
portray the range ofshapes for that chemical.
Prediction ofIn VivoDose-Response
Shape fromIn VitroData
Manyauthorshavesuggestedthatgenotoxiccompounds are
likelytoresultinlineardose-responserelationships(28-31)and
that nongenotoxic compounds will result in threshold or
nonlineardoseresponse. Thebeliefthatgenotoxicagentsinduce
lineardoseresponsestemsfromtheoreticalargumentsaboutone
molecule of a genotoxic compound interacting with DNA
resulting in a "single hit." The probability ofcancer is then
assumedtobeproportionaltothenumberof"hits" resultingin
a linear, no-threshold dose-response model. The nonlinear
shape for nongenotoxic compounds is based on mechanistic
arguments concerning cytotoxicity, and promotion, mecha-
nisms that are generally thought to be threshold mediated or
nonlinear. Weareinterestedinwhetherthecarcinogenicitydata
supportthistheory. Althoughitwouldbedifficulttorejectorac-
ceptitonthebasisofbioassaydata, withadatabasethislarge,
weshouldatleastseeshapepatternsthatconformtothistheory.
Toevaluatetherelationshipbetweengenotoxicity anddose-
responseshape, werepeatedtheanalysisoftheprevioussection,
stratifying chemicals into those that are mutagenic using the
AmesSalmonellaassayandthosethatarenot. Achemicalwas
labeled as a positive mutagen if it was positive in any ofthe
various Salmonellaassays conductedby the NTP(32). Table 3
illustrates the results. There were 367 sex-by-species-by-
chemical groups (Table 3, caseA) forwhichthecarcinogenesis
responsewassignificantatthe 1 % level(p<0.01); 230(63%)
were positive in the Salmonella assay, and 137 (37%) were
negative. Mostofthe sites adequately fitallthreeofthedose-
response models, with 65% (150/230) ofthe mutagenic com-
pounds fitting all three models, and 67% (92/137) fitting all
Table3. Consistency ofcarcinogenesis data with square root, linear, and
quadratic dose-responsemodelsca by mutgeici inSalmonella.
PartA:Testing forconsistency withvariousmodels
Salmonella L,SR, L,SR, LQ SR L Q None None
test Q notQ notSR only only only but <SR but >Q
+ 150 18 18 5 1 21 1 16
- 92 16 10 2 0 13 0 4
PartB: Best fitsa
Salmonella
test SR L Q Total
+ 78 (33.91) 43 (18.7) 109(47.4) 230
- 41 (29.9) 27 (19.7) 69 (50.4) 137
Part C: Classifying chemicalsC
Salmonella
CaseC test SR L Q Mixed Total
A + 0(0.0) 1(1.1) 28(31.5) 60(67.4) 89
- 5 (6.6) 8(10.5) 31 (40.8) 32 (42.1) 76
B + 25 (10.9) 21 (9.1) 91 (36.6) 93 (40.4) 230
- 23 (16.8) 19 (13.9) 63 (46.0) 32 (23.4) 137
Abbreviations: SR, square root; L, linear; Q, quadratic.
aFor each sex/species/route/chemical combination examined, the cases
reported areforthetissuesitewiththemaximum slope forthedose-response
curve underthelinear model.
bNumbers inparentheses arepercents.
CEntries arethenumberofdatasetsforwhichallsignificanttumorsiteswere
best fitby square root, linear, etc.
CThe cases are (A) each chemical (multiple routes andtechnical reports are
treatedasdifferentchemicals)formsonedatasettestedatthe0.01 level; (B)each
sex-by-species-by-chemicalcombinationforms onedataset,testedatthe0.01
level.
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three modelsforsitesfromnonmutageniccompounds. Ifwelook
atthe bestfittingdose-response model (Table2, partB), there
were no significantdifferences foundby dividingthe sites into
those for mutagenic compounds and those for nonmutagenic
compounds. As before, analyses by sex and/orspeciesyielded
similar results.
InTable3, part3, the results aregroupedby chemicals inthe
same manner as Table 2, part 3. Looking at chemicals alone
(Table 3, caseA), 97% (28/29)oftheSalmonellapositiveswith
only one shape were quadratic, and only 70% (31/44) of the
Salmonella negatives were quadratic. The same pattern is
observed for the sex-by-species-by-chemical classification
(Table3, caseB). Thus, we seeapatternofdose-resronseshapes
that is exactly opposite tothetheoretical patterns suggested for
genotoxic andnongenotoxiccompounds. Cautionmustbeexer-
cised in interpreting the overall shape of chemicals that are
Salmonella positive versus those that are Salmonella negative
becausechemicalsthat areSalmonellapositive are morelikely
to have multiple significant tumor sites than are Salmonella
negativechemicals (78% ofthepositiveshad3 ormoresignifi-
cant tumor sites ascompared to61% ofthenegatives). Thus, it
is easier to label a Salmonella-negative chemical as having a
singleshape(thisisobviouswhenyoulookatthe "mixed" col-
umnofTable3, partC). Forthechemicalswithquadraticshape,
thereisonlyaslightdifferenceinthenumberofsignificantsites
forSalmonella-positive versusSalmonella-negative chemicals
(i.e., ofthe 14 quadratic chemicals with 3 or more significant
sites, 6 were Salmonellapositive and 8 were negative).
From these data, there is noevidence to supportthe assump-
tion that a positive finding of mutagenicity in Salmonella is
predictive of a linear dose-response relationship for car-
cinogenicity, noristhereevidencethatanonpositivemutagenici-
tyfindingispredictiveofanonlineardose-responserelationship.
This analysis was repeated for other short-term assays of
genotoxicityincludingtheanalysisofsex-linkedrecessivelethals
andreciprocal translocations inDrosophila, chromosomalaber-
rations andsisterchromatidexchangesinChinesehamsterovary
cells, andthe mouselymphoma(LS1784)cellmutagenesisassay.
There were fewer chemicals tested in these assays relative to
Salmonella. No significant differences were noted between
positives and negatives in these assays, and the prediction of
dose-response shape was similar (or even less informative) to
what was observed for Salmonella.
Discussion
The analysis in this study suggests that the carcinogenic dose
responseobservedinanimalstudiesisoftennonlinear,thecancer
riskincreasingwithdoseatarategreaterthanwhatwouldbeex-
pected iftheeffect wereproportional todose. Becausethelinear
model wouldoverestimate risk atthelowestexperimentaldose
inthesecases, itislikelythatthismodelwouldalsooverestimate
the cancerrisk atthelowdosestypicalofhumanexposurelevels.
Themagnitude ofthisoverestimationisunknown, anddepends
on how far fromtheexperimental range onewishes toestimate
effects. Ithasbeen shownpreviouslythatbyconsideringsimple
hypothetical kineticmodels(2,3,14,18), onecouldoverestimate
low-dose riskby afactorupwardsof500withoutassumingany
thresholdbehaviorbutbysimplylettingcancerincidencebepro-
portional to abiologicallyeffectivedose. Inothermodels, such
as in human cancers resulting from radiation exposure, where
one may choose between a linear dose response and a purely
quadratic one with exponential cell killing, the riskestimation
easily provides a difference ofa factor of 100 in the exposure
rangeof1 rad(33). Ontheotherhand, thereareexamples(34),
albeit uncommon, of the square-root type response that can
resultintheunderestimationofriskusinglinearmodels. These
require careful analysis.
Baileretal. (26)analyzedthecarcinogenesisbioassaydatafor
308chemicalsstudiedbytheNCIandtheNTP. Fittingtheone-
hitmodel (Eq. 1) tothesedata, theyconcludedthat "theone-hit
formula... .often underestimates lifetime cancer risks in the
observablerange." Thisconclusionresultsfromobservingthat
asizeableportionoftheexperimentswithonly twodosegroups
hadresponseatthemiddle-dosegrouphigherthanwhatwould
be predicted by a line drawn from the control response to the
high-dose response.
Bailer et al.'s (26) analysis differed from ours in several key
aspects. Thethreemajordifferencesareinthechoiceofdatasets,
the statisticalmethods, andthe restrictions employed to obtain
subsets ofthedata for analysis. Baileretal. (26) concentrated
theiranalysisonall sex/species/tumorsites inthedata set with
a brief description of a few restrictive analyses concerning
significanttumorresponseandgoodnessoffit. Inouranalysis,
weconsideredonly data sets for which the modified trend test
was significantbecause it is unlikely that acceptable exposure
levels would be estimated for tumor sites without significant
tumorrisks. They concentrated on curvature withoutregard to
theadequacy ofthe fittedmodel, whereas we looked into how
ofteneachdose-responseshapefitordidnotfitthebioassaydata.
Thus, although they observed a large number ofsquare-root-
shaped data sets, the majority of these agree with the linear
model. Ofthe390experiments with asignificanttumorriskat
the 1% level(Table2, caseA), only 8 canbelabeled as clearly
square-rootmodels. Inaddition, iftruthweretheone-hitmodel,
itcouldbeexpectedthat, ofthosemodelsforwhichthelinearwas
not the best fit, 50% would be square-root shaped and 50%
would be quadratic shaped. Instead, we find that only 34%
(202/594) are square-root shaped, suggesting the general ten-
dencyofthesedataistowardquadraticcurvature, notsquare-root
curvature. Thisshouldnotbeconstruedasinvalidatingthefind-
ings of Bailer et al. (26). They basically pointed out that the
linearmodelis notthemostconservativemodeltouseformany
ofthesedata. Weagreewiththisfinding. Itisnotclear, however,
whetherupperboundsonriskbasedonthelinearmodelaresuf-
ficiently conservative to protect against a square-root model.
Whatwehaveshownisthat, foraratherlargepercentageofthe
data,thereisageneraltendencytowardquadraticdoseresponse,
suggestingthatthelinearmodelwillbeextremelyconservative
in many cases.
Wehavealsofoundthattheoft-heldbeliefthatgenotoxiccom-
poundstypicallyfollowalineardose-responsepatternandthat
nongenotoxiccompoundsfollowanonlinearorthresholddose-
responsepatternis notsupportedbythedata. Infact, wefindthe
opposite, with genotoxic compounds differing from linearity
moreoftenthannongenotoxiccompounds. Metabolicprocesses
(e.g., activation,deactivation,detoxification), biochemicalpro-
cesses (e.g., DNA damage, repair), other cellular processes
(e.g., mitosis), thecompetenceoftheimmune system, etc., all
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play an important role in carcinogenic response to chemicals.
Becauseeachofthese systemsorprocessescanbealteredbythe
presence of a chemical and each will have its own shape for
response tovaryingchemical dose, thedose-response shapefor
tumor incidence will be acomplicatedcollection ofallofthese
shapes. Thus, ashasbeenstatedpreviously (35,36), topresume
thatknowledgeofthepresenceorabsenceofchemicaleffectson
one process (DNA damage) is sufficient to explain dose-
response shape is naive.
Allofthisis notto saythatlinearlow-doseextrapolationisnot
the best policy from a public health standpoint. However, the
studyresultsimplythatusinglinearriskestimationmayleadto
risks thatoften areoverestimated based the experimental data.
Although the carcinogenesis data suggest nonlinearity more
often thanlinearity, they make no statementaboutthepresence
or absence ofthreshold levels. With simple, nonlinear kinetic
models, onestillobtains linearityofresponseatlow-doselevels
(3). Forpurposesoflow-doseriskestimationanddetermination
ofdose-responserelationships, dose-responseinformationfrom
other systems such as DNA adduct formation, toxicokinetics,
and cellular proliferation should be coupled with the car-
cinogenesis dataforlow-doseriskestimation. Thisapproachto
carcinogenic riskestimation would incorporate biologically per-
tinent and measurable parameters into the uncertain and
politically volatile business of public health management of
chemical carcinogens.
The authorsappreciate the helpful comments made by B. Ames, M. Ander-
son, L. Gold, and P. Williams.
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